Lifeline Biotechnologies (LLBO) Stock Price & Analysis
LLBO Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- 10.21K
- Average Volume (3M)
- N/A
- Market Cap
- $1.30M
- Enterprise Value
- $10.37T
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- 486.61
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
LLBO FAQ
What is Lifeline Biotechnologies’s market cap?
When is Lifeline Biotechnologies’s upcoming earnings report date?
Is Lifeline Biotechnologies overvalued?
Does Lifeline Biotechnologies pay dividends?
What is Lifeline Biotechnologies’s EPS estimate?
How many shares outstanding does Lifeline Biotechnologies have?
Which hedge fund is a major shareholder of Lifeline Biotechnologies?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Lifeline Biotechnologies
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.
- Sector
- Financial
- Industry
- Medical - Specialties
- CEO
- Caren Currier
- Employees
- 0
- Website
- www.lbti.co
- Address
- 2313 Hollyhill Lane, Reno, TX, 76205, US
